BioMarin Pharmaceutical (BMRN) Revenue by Segment

History

Date	Voxzogo	Naglazyme	Palynziq	Brineura	Aldurazyme	Kuvan	Roctavian	Royalty and Other
Jun 30, 2026	963.41M	507.33M	458.73M	195.47M	183.28M	95.32M	30.35M	42.01M
Mar 31, 2026	932.27M	500.94M	429.50M	192.80M	196.18M	97.91M	27.84M	49.12M
Dec 31, 2025	926.39M	484.87M	432.94M	185.69M	208.44M	99.03M	36.20M	53.49M
Sep 30, 2025	861.39M	474.87M	407.94M	184.69M	198.44M	104.03M	34.20M	49.93M
Jun 30, 2025	833.19M	484.77M	389.54M	173.69M	215.44M	108.13M	38.40M	46.51M
Mar 31, 2025	795.70M	487.90M	371.90M	170.30M	197.60M	109.70M	36.60M	43.98M
Dec 31, 2024	734.60M	479.50M	354.60M	169.30M	183.90M	120.60M	26.40M	44.48M
Sep 30, 2024	672.30M	467.80M	342.40M	164.90M	187.60M	129.30M	18.10M	45.90M
Jun 30, 2024	605.50M	444.80M	330.70M	168.90M	130.40M	144.10M	11.70M	47.10M
Mar 31, 2024	534.90M	402.90M	317.30M	161.70M	132.10M	166.10M	4.30M	47.80M
Dec 31, 2023	469.80M	420.30M	304.00M	161.80M	131.20M	180.70M	3.50M	46.80M
Sep 30, 2023	390.90M	422.50M	288.50M	160.80M	126.20M	197.60M	800.00K	45.70M
Jun 30, 2023	316.20M	413.10M	275.80M	157.60M	141.40M	211.70M	-	44.60M
Mar 31, 2023	237.30M	438.80M	262.50M	157.20M	138.40M	218.70M	-	50.10M
Dec 31, 2022	169.20M	443.80M	255.00M	154.30M	128.40M	227.50M	-	53.90M
Sep 30, 2022	108.10M	426.40M	246.50M	149.10M	110.90M	242.40M	-	56.50M
Jun 30, 2022	59.90M	398.10M	241.00M	144.30M	106.30M	253.10M	-	59.40M
Mar 31, 2022	25.50M	401.10M	238.30M	136.90M	97.10M	274.30M	-	58.30M
Dec 31, 2021	5.80M	380.40M	237.40M	128.00M	122.70M	285.80M	-	62.80M
Sep 30, 2021	100.00K	417.00M	223.20M	125.60M	103.70M	306.40M	-	63.30M